Saronno, Italy

Paolo Elia Cappella

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Elia Cappella. Retrieved from https://idiyas.com/inventor/paolo-elia-cappella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paolo Elia Cappella: Innovator in Pharmaceutical Composition

Introduction

Paolo Elia Cappella is a notable inventor based in Saronno, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for cancer treatment. His work is characterized by a focus on improving therapeutic options for patients.

Latest Patents

Cappella holds a patent for a pharmaceutical composition of an anthracycline. This invention relates to a composition containing nemorubicin hydrochloride incorporated in microspheres. The compositions are particularly useful for chemoembolization, especially for loco-regional treatment of tumors. This patent highlights his commitment to advancing cancer therapies.

Career Highlights

Cappella is associated with Nerviano Medical Sciences S.r.l., a company dedicated to the research and development of innovative cancer treatments. His role in this organization underscores his expertise and dedication to improving patient outcomes through scientific innovation.

Collaborations

Throughout his career, Cappella has collaborated with esteemed colleagues, including Maria Cristina Geroni and Olga Valota. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Paolo Elia Cappella's work in pharmaceutical innovation exemplifies the impact of dedicated inventors in the medical field. His contributions, particularly in cancer treatment, continue to pave the way for future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…